Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.385 USD | +8.20% | +11.69% | +140.87% |
Apr. 22 | Chardan Adjusts Price Target on Ocugen to $5 From $4, Maintains Buy Rating | MT |
Apr. 22 | Chardan Raises Price Target on Ocugen to $5 From $4, Keeps Buy Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+140.87% | 329M | |
+1.54% | 42.75B | |
+47.70% | 41.61B | |
+11.95% | 41.34B | |
-8.83% | 26.59B | |
+6.34% | 25.49B | |
-23.26% | 18.12B | |
+29.92% | 12.24B | |
-2.58% | 11.76B | |
+8.17% | 11B |
- Stock Market
- Equities
- OCGN Stock
- News Ocugen, Inc.
- Ocugen Says Data, Safety Monitoring Board Issues 'Positive' Review of Eye Disease Treatment -- Shares Rise